Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 56 citing articles:

Berberine targets KIF20A and CCNE2 to inhibit the progression of nonsmall cell lung cancer via the PI3K/AKT pathway
Qi Wang, Hua Wu, Qingquan Wu, et al.
Drug Development Research (2023) Vol. 84, Iss. 5, pp. 907-921
Closed Access | Times Cited: 16
Prospective validation of ORACLE, a clonal expression biomarker associated with survival of patients with lung adenocarcinoma
Dhruva Biswas, Yun-Hsin Liu, Javier Herrero, et al.
Nature Cancer (2025)
Open Access
Epigenetic modifications in early stage lung cancer: pathogenesis, biomarkers, and early diagnosis
Lingfeng Bi, Xin Wang, Jiayi Li, et al.
MedComm (2025) Vol. 6, Iss. 3
Open Access
Ferroptosis-Related Gene GCLC Is a Novel Prognostic Molecular and Correlates with Immune Infiltrates in Lung Adenocarcinoma
Lianxiang Luo, Zhentao Zhang, Yanmin Weng, et al.
Cells (2022) Vol. 11, Iss. 21, pp. 3371-3371
Open Access | Times Cited: 18
Identification of prognostic biomarkers of smoking-related lung cancer
Liang Chen, Wei Pan, Zhijun Zhou, et al.
Journal of Thoracic Disease (2024) Vol. 16, Iss. 2, pp. 1438-1449
Open Access | Times Cited: 3
Deciphering the tumor microenvironment cell–infiltrating landscape reveals microenvironment subtypes and therapeutic potentials for nonsquamous NSCLC
Hao Chen, Tongchao Zhang, Yuan Zhang, et al.
JCI Insight (2022) Vol. 7, Iss. 12
Open Access | Times Cited: 13
A risk score model with five long non-coding RNAs for predicting prognosis in gastric cancer: an integrated analysis combining TCGA and GEO datasets
Yiguo Wu, Junping Deng, Shuhui Lai, et al.
PeerJ (2021) Vol. 9, pp. e10556-e10556
Open Access | Times Cited: 16
Screening of novel tumor-associated antigens for lung adenocarcinoma mRNA vaccine development based on pyroptosis phenotype genes
Fang Zhou, Meng Wang, Zheng Wang, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Comprehensive molecular analyses of cuproptosis-related genes with regard to prognosis, immune landscape, and response to immune checkpoint blockers in lung adenocarcinoma
Ruixia Li, Run Tong, Jasmine Lin Zhang, et al.
Journal of Cancer Research and Clinical Oncology (2024) Vol. 150, Iss. 5
Open Access | Times Cited: 2
The roles of E2F7 in cancer: Current knowledge and future prospects
Ke-qian Chen, Hai-bo Lei, Xiang Liu, et al.
Heliyon (2024) Vol. 10, Iss. 14, pp. e34362-e34362
Open Access | Times Cited: 2
The Ubiquitin E3 Ligase FBXO33 Suppresses Stem Cell-Like Properties and Metastasis in Non-Small-Cell Lung Cancer by Promoting Ubiquitination and Degradation of Myc
Qiong Wei, Zichun Liu, Jing Zhu, et al.
Frontiers in Bioscience-Landmark (2024) Vol. 29, Iss. 8
Open Access | Times Cited: 2
circPlekha7 suppresses renal fibrosis via targeting miR-493-3p/KLF4
Wa Zhou, Yan-Xia Chen, Ben Ke, et al.
Epigenomics (2022) Vol. 14, Iss. 4, pp. 199-217
Closed Access | Times Cited: 10
Screening of potential biomarkers for polycystic ovary syndrome and identification of expression and immune characteristics
Shuang Liu, Xuanpeng Zhao, Qingyan Meng, et al.
PLoS ONE (2023) Vol. 18, Iss. 10, pp. e0293447-e0293447
Open Access | Times Cited: 6
Immune Checkpoint Gene Expression Profiling Identifies Programmed Cell Death Ligand-1 Centered Immunologic Subtypes of Oral and Squamous Cell Carcinoma With Favorable Survival
Yang Yu, Huiwen Tang, Debora Franceschi, et al.
Frontiers in Medicine (2022) Vol. 8
Open Access | Times Cited: 9
MDFI is a novel biomarker for poor prognosis in LUAD
Pengyu Chen, Zhen Quan, Xueyu Song, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 9
Transcriptomic data in tumor‐adjacent normal tissues harbor prognostic information on multiple cancer types
Euiyoung Oh, Hyunju Lee
Cancer Medicine (2023) Vol. 12, Iss. 10, pp. 11960-11970
Open Access | Times Cited: 5
Evaluating the Expression and Prognostic Value of Genes Encoding Microtubule-Associated Proteins in Lung Cancer
Natsaranyatron Singharajkomron, Varalee Yodsurang, Suthasinee Seephan, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 14724-14724
Open Access | Times Cited: 8
Network pharmacology prediction and molecular docking-based strategy to discover the potential pharmacological mechanism of action of Wang Bu Liu Xing (Semen vaccariae) for colorectal cancer
Yongquan Shi, Yunshu Zhang, Jifeng Liu, et al.
Journal of Gastrointestinal Oncology (2023) Vol. 14, Iss. 2, pp. 504-515
Open Access | Times Cited: 4
Macrophage-Related Gene Signatures for Predicting Prognosis and Immunotherapy of Lung Adenocarcinoma by Machine Learning and Bioinformatics
Yunzhi Xiang, Guanghui Wang, Baoliang Liu, et al.
Journal of Inflammation Research (2024) Vol. Volume 17, pp. 737-754
Open Access | Times Cited: 1
Weighted Gene Co-expression Network Analysis and Machine Learning Validation for Identifying Major Genes Related to Sjogren’s Syndrome
Qiang Luo, Kaiwen Wu, He Li, et al.
Biochemical Genetics (2024)
Closed Access | Times Cited: 1
Succinylation of 14–3–3 theta by CPT1A promotes survival and paclitaxel resistance in nasal type extranodal natural killer/T-cell lymphoma
Xiaobing Cui, Chengcheng Cao, Xinyang Li, et al.
Translational Oncology (2024) Vol. 46, pp. 102006-102006
Open Access | Times Cited: 1
Glucose metabolism transcriptome clustering identifies subsets of resectable lung adenocarcinoma with different prognosis.
Enzo Alifano, Mathilde Prieto, Marco Alifano
JTCVS Open (2024)
Open Access | Times Cited: 1
Identification of G6PC as a potential prognostic biomarker in hepatocellular carcinoma based on bioinformatics analysis
Li Tian, Yong Liao
Medicine (2022) Vol. 101, Iss. 33, pp. e29548-e29548
Open Access | Times Cited: 7
Exosomal circ-ADRM1 promotes lung adenocarcinoma progression and induces macrophage M2 polarization through regulating MMP14 mRNA and protein
Jun Qian, Jie Li, Haitao Ma, et al.
Anti-Cancer Drugs (2022)
Closed Access | Times Cited: 7
Development and Validation of a Prognostic Nomogram for Lung Adenocarcinoma: A Population-Based Study
Bin Xie, Xi Chen, Qi Deng, et al.
Journal of Healthcare Engineering (2022) Vol. 2022, pp. 1-13
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top